CONMED CORP (CNMD) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CNMD - US2074101013 - Common Stock
41.57 USD
-0.98 (-2.3%)
41.57 USD
0 (0%)
Overall CNMD gets a fundamental rating of 6 out of 10. We evaluated CNMD against 185 industry peers in the Health Care Equipment & Supplies industry. While CNMD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CNMD may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
- In the past year CNMD was profitable.
- CNMD had a positive operating cash flow in the past year.
- CNMD had positive earnings in 4 of the past 5 years.
- In the past 5 years CNMD always reported a positive cash flow from operatings.
1.2 Ratios
- With a decent Return On Assets value of 2.77%, CNMD is doing good in the industry, outperforming 76.34% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 6.38%, CNMD is in the better half of the industry, outperforming 79.57% of the companies in the same industry.
- CNMD has a Return On Invested Capital of 5.39%. This is in the better half of the industry: CNMD outperforms 77.42% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for CNMD is below the industry average of 8.84%.
- The last Return On Invested Capital (5.39%) for CNMD is above the 3 year average (5.34%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.77% | ||
| ROE | 6.38% | ||
| ROIC | 5.39% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
1.3 Margins
- The Profit Margin of CNMD (4.77%) is better than 76.88% of its industry peers.
- In the last couple of years the Profit Margin of CNMD has grown nicely.
- CNMD has a better Operating Margin (9.99%) than 78.49% of its industry peers.
- In the last couple of years the Operating Margin of CNMD has grown nicely.
- With a Gross Margin value of 54.22%, CNMD perfoms like the industry average, outperforming 51.61% of the companies in the same industry.
- CNMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.99% | ||
| PM (TTM) | 4.77% | ||
| GM | 54.22% |
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CNMD is destroying value.
- Compared to 1 year ago, CNMD has more shares outstanding
- CNMD has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, CNMD has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 1.88 indicates that CNMD is not a great score, but indicates only limited risk for bankruptcy at the moment.
- CNMD has a Altman-Z score (1.88) which is comparable to the rest of the industry.
- CNMD has a debt to FCF ratio of 5.74. This is a neutral value as CNMD would need 5.74 years to pay back of all of its debts.
- The Debt to FCF ratio of CNMD (5.74) is better than 77.96% of its industry peers.
- CNMD has a Debt/Equity ratio of 0.85. This is a neutral value indicating CNMD is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.85, CNMD is not doing good in the industry: 73.12% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 5.74 | ||
| Altman-Z | 1.88 |
ROIC/WACC0.61
WACC8.91%
2.3 Liquidity
- CNMD has a Current Ratio of 2.10. This indicates that CNMD is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of CNMD (2.10) is comparable to the rest of the industry.
- CNMD has a Quick Ratio of 2.10. This is a bad value and indicates that CNMD is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.95, CNMD is doing worse than 78.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.1 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
- CNMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.49%, which is quite good.
- Measured over the past years, CNMD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.44% on average per year.
- The Revenue has been growing slightly by 4.61% in the past year.
- CNMD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.47% yearly.
EPS 1Y (TTM)16.49%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%2.86%
Revenue 1Y (TTM)4.61%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%6.7%
3.2 Future
- Based on estimates for the next years, CNMD will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.44% on average per year.
- Based on estimates for the next years, CNMD will show a small growth in Revenue. The Revenue will grow by 5.19% on average per year.
EPS Next Y10.38%
EPS Next 2Y5.01%
EPS Next 3Y6.36%
EPS Next 5Y9.44%
Revenue Next Year5.12%
Revenue Next 2Y2.86%
Revenue Next 3Y3.63%
Revenue Next 5Y5.19%
3.3 Evolution
- The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- CNMD is valuated reasonably with a Price/Earnings ratio of 9.20.
- Based on the Price/Earnings ratio, CNMD is valued cheaply inside the industry as 94.62% of the companies are valued more expensively.
- CNMD is valuated cheaply when we compare the Price/Earnings ratio to 27.47, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 9.06, which indicates a very decent valuation of CNMD.
- Based on the Price/Forward Earnings ratio, CNMD is valued cheaply inside the industry as 95.70% of the companies are valued more expensively.
- CNMD is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.26, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.2 | ||
| Fwd PE | 9.06 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CNMD is valued cheaply inside the industry as 91.40% of the companies are valued more expensively.
- CNMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CNMD is cheaper than 98.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.66 | ||
| EV/EBITDA | 10.07 |
4.3 Compensation for Growth
- CNMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- CNMD has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.89
PEG (5Y)0.97
EPS Next 2Y5.01%
EPS Next 3Y6.36%
5. Dividend
5.1 Amount
- CNMD has a Yearly Dividend Yield of 1.88%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 0.19, CNMD pays a better dividend. On top of this CNMD pays more dividend than 95.70% of the companies listed in the same industry.
- CNMD's Dividend Yield is comparable with the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.88% |
5.2 History
- The dividend of CNMD decreases each year by -0.01%.
- CNMD has been paying a dividend for at least 10 years, so it has a reliable track record.
- CNMD has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years12
5.3 Sustainability
- 39.73% of the earnings are spent on dividend by CNMD. This is a low number and sustainable payout ratio.
DP39.73%
EPS Next 2Y5.01%
EPS Next 3Y6.36%
41.57
-0.98 (-2.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)01-28 2026-01-28/amc
Inst Owners114.3%
Inst Owner Change-0.17%
Ins Owners0.29%
Ins Owner Change0.35%
Market Cap1.29B
Revenue(TTM)1.35B
Net Income(TTM)64.32M
Analysts73.33
Price Target49.37 (18.76%)
Short Float %7.67%
Short Ratio4.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.88% |
Yearly Dividend0.8
Dividend Growth(5Y)-0.01%
DP39.73%
Div Incr Years0
Div Non Decr Years12
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.52%
Min EPS beat(2)0.37%
Max EPS beat(2)0.66%
EPS beat(4)4
Avg EPS beat(4)6.26%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)7
Avg EPS beat(8)4.08%
EPS beat(12)10
Avg EPS beat(12)-0.4%
EPS beat(16)13
Avg EPS beat(16)0.52%
Revenue beat(2)0
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-1.03%
Max Revenue beat(2)-0.75%
Revenue beat(4)1
Avg Revenue beat(4)-0.45%
Min Revenue beat(4)-1.03%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-1.24%
Revenue beat(12)3
Avg Revenue beat(12)-1.58%
Revenue beat(16)4
Avg Revenue beat(16)-1.61%
PT rev (1m)-10.37%
PT rev (3m)-21.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.42%
EPS NY rev (1m)0%
EPS NY rev (3m)0.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.2 | ||
| Fwd PE | 9.06 | ||
| P/S | 0.96 | ||
| P/FCF | 8.66 | ||
| P/OCF | 7.69 | ||
| P/B | 1.28 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.07 |
EPS(TTM)4.52
EY10.87%
EPS(NY)4.59
Fwd EY11.04%
FCF(TTM)4.8
FCFY11.55%
OCF(TTM)5.4
OCFY13%
SpS43.51
BVpS32.56
TBVpS-12.65
PEG (NY)0.89
PEG (5Y)0.97
Graham Number57.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.77% | ||
| ROE | 6.38% | ||
| ROCE | 6.7% | ||
| ROIC | 5.39% | ||
| ROICexc | 5.5% | ||
| ROICexgc | 19.04% | ||
| OM | 9.99% | ||
| PM (TTM) | 4.77% | ||
| GM | 54.22% | ||
| FCFM | 11.04% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
ROICexc(3y)5.41%
ROICexc(5y)5.04%
ROICexgc(3y)20.03%
ROICexgc(5y)18.26%
ROCE(3y)6.64%
ROCE(5y)6.18%
ROICexgc growth 3Y14.62%
ROICexgc growth 5Y8.81%
ROICexc growth 3Y13.67%
ROICexc growth 5Y10.96%
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
F-Score5
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 5.74 | ||
| Debt/EBITDA | 4.09 | ||
| Cap/Depr | 25.13% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 80.15% | ||
| Profit Quality | 231.2% | ||
| Current Ratio | 2.1 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | 1.88 |
F-Score5
WACC8.91%
ROIC/WACC0.61
Cap/Depr(3y)25.34%
Cap/Depr(5y)23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.49%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%2.86%
EPS Next Y10.38%
EPS Next 2Y5.01%
EPS Next 3Y6.36%
EPS Next 5Y9.44%
Revenue 1Y (TTM)4.61%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%6.7%
Revenue Next Year5.12%
Revenue Next 2Y2.86%
Revenue Next 3Y3.63%
Revenue Next 5Y5.19%
EBIT growth 1Y-35.26%
EBIT growth 3Y23.86%
EBIT growth 5Y16.64%
EBIT Next Year42.06%
EBIT Next 3Y15.06%
EBIT Next 5YN/A
FCF growth 1Y296.53%
FCF growth 3Y16.67%
FCF growth 5Y15.46%
OCF growth 1Y191.56%
OCF growth 3Y14.3%
OCF growth 5Y11.92%
CONMED CORP / CNMD FAQ
What is the ChartMill fundamental rating of CONMED CORP (CNMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CNMD.
Can you provide the valuation status for CONMED CORP?
ChartMill assigns a valuation rating of 8 / 10 to CONMED CORP (CNMD). This can be considered as Undervalued.
How profitable is CONMED CORP (CNMD) stock?
CONMED CORP (CNMD) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for CNMD stock?
The Price/Earnings (PE) ratio for CONMED CORP (CNMD) is 9.2 and the Price/Book (PB) ratio is 1.28.
What is the expected EPS growth for CONMED CORP (CNMD) stock?
The Earnings per Share (EPS) of CONMED CORP (CNMD) is expected to grow by 10.38% in the next year.